194 related articles for article (PubMed ID: 30132831)
1. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M
Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831
[TBL] [Abstract][Full Text] [Related]
2. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
[TBL] [Abstract][Full Text] [Related]
3. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Capasso M; Devoto M; Hou C; Asgharzadeh S; Glessner JT; Attiyeh EF; Mosse YP; Kim C; Diskin SJ; Cole KA; Bosse K; Diamond M; Laudenslager M; Winter C; Bradfield JP; Scott RH; Jagannathan J; Garris M; McConville C; London WB; Seeger RC; Grant SF; Li H; Rahman N; Rappaport E; Hakonarson H; Maris JM
Nat Genet; 2009 Jun; 41(6):718-23. PubMed ID: 19412175
[TBL] [Abstract][Full Text] [Related]
4. Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.
Latorre V; Diskin SJ; Diamond MA; Zhang H; Hakonarson H; Maris JM; Devoto M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):658-63. PubMed ID: 22328350
[TBL] [Abstract][Full Text] [Related]
5. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.
Zhang R; Zou Y; Zhu J; Zeng X; Yang T; Wang F; He J; Xia H
Int J Med Sci; 2016; 13(2):133-8. PubMed ID: 26941572
[TBL] [Abstract][Full Text] [Related]
6. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.
Bosse KR; Diskin SJ; Cole KA; Wood AC; Schnepp RW; Norris G; Nguyen le B; Jagannathan J; Laquaglia M; Winter C; Diamond M; Hou C; Attiyeh EF; Mosse YP; Pineros V; Dizin E; Zhang Y; Asgharzadeh S; Seeger RC; Capasso M; Pawel BR; Devoto M; Hakonarson H; Rappaport EF; Irminger-Finger I; Maris JM
Cancer Res; 2012 Apr; 72(8):2068-78. PubMed ID: 22350409
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM
Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269
[TBL] [Abstract][Full Text] [Related]
8. BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.
Fu W; Zhu J; Xiong SW; Jia W; Zhao Z; Zhu SB; Hu JH; Wang FH; Xia H; He J; Liu GC
EBioMedicine; 2017 Feb; 16():101-105. PubMed ID: 28161399
[TBL] [Abstract][Full Text] [Related]
9. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
J Natl Cancer Inst; 2024 Jan; 116(1):138-148. PubMed ID: 37688570
[TBL] [Abstract][Full Text] [Related]
10. The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population.
Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Carrera I; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Santos JL; Jara L
Mol Biol Rep; 2012 Aug; 39(8):8091-8. PubMed ID: 22544576
[TBL] [Abstract][Full Text] [Related]
11. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.
Huo X; Hu Z; Zhai X; Wang Y; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wei Q; Wang X; Shen H
Breast Cancer Res Treat; 2007 May; 102(3):329-37. PubMed ID: 17028982
[TBL] [Abstract][Full Text] [Related]
12. Association of BARD1 and BRIP1 Gene Polymorphisms with the Risk of Uveal Melanoma.
Mukhana L; Aissa AA; Ahmed AAM; Saakyan SV; Tsygankov AY; Blagonravov ML; Azova MM
Bull Exp Biol Med; 2023 Jul; 175(3):399-403. PubMed ID: 37561379
[TBL] [Abstract][Full Text] [Related]
13. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
[TBL] [Abstract][Full Text] [Related]
14. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide pathway analysis in neuroblastoma.
Lee YH; Kim JH; Song GG
Tumour Biol; 2014 Apr; 35(4):3471-85. PubMed ID: 24293394
[TBL] [Abstract][Full Text] [Related]
16. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
17. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.
Nguyen le B; Diskin SJ; Capasso M; Wang K; Diamond MA; Glessner J; Kim C; Attiyeh EF; Mosse YP; Cole K; Iolascon A; Devoto M; Hakonarson H; Li HK; Maris JM
PLoS Genet; 2011 Mar; 7(3):e1002026. PubMed ID: 21436895
[TBL] [Abstract][Full Text] [Related]
18. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
19. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani NL; Dymek M; Desai H; Hausler R; Hicks B; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
J Natl Cancer Inst; 2024 Jan; 116(1):149-159. PubMed ID: 37688579
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.
Pilyugin M; Irminger-Finger I
Int J Biochem Cell Biol; 2014 Sep; 54():356-67. PubMed ID: 25008968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
